International news
Mar 26, 2018Bold action’ needed to end tuberculosis, AIDSUN News - "Claiming more than 4,500 lives daily, tuberculosis (TB) continues to be the top infectious killer worldwide as well as the leading cause of death among people living with HIV, the United Nations said Friday, ahead of World Tuberculosis Day. |
Mar 26, 2018Peter Sands: charting a new course for The Global FundThe Lancet - "Peter Sands had a stormy start before taking up his new position as Executive Director of The Global Fund to Fight AIDS, Tuberculosis and Malaria on March 5, 2018. He was plunged into controversy last month after the decision by The Global Fund's senior management team to partner with Heineken, among other multinationals, and the implications for global health. |
Mar 19, 2018Meeting is first step towards ending Global Fund’s ill-advised Heineken partnership, though concerns remainNCD-Alliance - "The inappropriate partnership between the Global Fund and Heineken was the topic of discussion between Marijke Wijnroks, Interim Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, and representatives of IOGT International, the Global Alcohol Policy Alliance, and NCD Alliance last Friday in Geneva. |
Mar 14, 2018Alliance joins call to reverse unpopular AIDS2020 host city decisionwww.aidsalliance.org - "This week, the International AIDS Society announced its decision to name San Francisco and Oakland as host cities to the International AIDS Conference in 2020 (AIDS2020). Sadly, this decision does not consider the ongoing concerns raised by civil society organisations and key population networks on the adverse implications of this decision. |
Mar 02, 2018Novartis must end ‘bullying tactics’ over life-saving medicinesSTOPAIDS - "Swiss multinational Novartis yesterday faced international calls from an alliance of health campaigners for an end to its ‘threats, lies and bribes’ towards governments over access to life-saving medicines, on the eve of the company’s AGM in Basel, Switzerland which took place today. |
Mar 01, 2018¡PrEP Ya! Latin America wants PrEP, and Brazil leads the wayThe Lancet - "Brazil has long been at the forefront of HIV treatment and prevention in Latin America. It was the first country in the region to make highly active antiretroviral therapy freely available and participated in the iPrEx study, which reported the efficacy of pre-exposure prophylaxis (PrEP) with daily oral emtricitabine and tenofovir disoproxil fumarate to prevent HIV acquisition in men who have sex with men (MSM) and transgender women. |